do glp 1 agonists have cardiovascular benefit The effects of GLP-1 receptor beyond obesity and type 2 diabetes: An anti-atherosclerotic action GLP-1 receptor agonists (GLP-1RAs): cardiovascular
Description
Haqq L, McFarlane J, Dieberg G, Smart N
The indication, dose, insurance coverage, and medical appropriateness depend on the specific medication and patient
95% CI, 1.412.75) in the CANVAS CVOT, which overall included 10,142 patients with T2DM and high cardiovascular risk [75]
Water pipe tobacco smoking and risk of Coronary Artery Disease: A systematic review and meta-analyses
Safety and tolerability The most common side effects of GLP-1RAs are gastrointestinal side effects, including nausea, vomiting, and diarrhea
Some researchers have moved their eyes to small-molecule GLP-1RA - with high oral bioavailability, and high patient compliance
